OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
May 01, 2022
What are the next steps for permanent authorization of COVID-19 vaccines, treatments, and diagnostics?
April 01, 2022
Quality metrics and more domestic production aim to avoid supply disruptions and drug shortages.
March 01, 2022
Califf will face challenges that include COVID-19, opioids, and user fees.
February 01, 2022
The global nature of the COVID-19 pandemic emphasizes the critical importance of expanded vaccination.
January 01, 2022
To maintain smooth operations, FDA is relying on swift reauthorization of industry-paid user fee programs.
December 01, 2021
The need for medicines to combat COVID-19 has impacted the way regulatory agencies carry out their operations.
November 01, 2021
New methods and policies necessitated by the global pandemic are slated to become permanent fixtures in FDA enforcement and regulatory programs.
October 15, 2021
After months of deliberation, Biden plans to appoint cardiologist Robert Califf as FDA commissioner.
October 01, 2021
A new program will test the safety and suitability of new inactive ingredients to encourage the accelerated adoption of FDA-accepted excipients in drug development.
September 01, 2021
Will FDA’s approval of Semglee create a surge in the development of interchangeable biosimilars?